DOCSLIB.ORG

Curbing Prescription Drug Abuse in Medicare Hearing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curbing Prescription Drug Abuse in Medicare Hearing S. Hrg. 113–244 CURBING PRESCRIPTION DRUG ABUSE IN MEDICARE HEARING BEFORE THE COMMITTEE ON HOMELAND SECURITY AND GOVERNMENTAL AFFAIRS UNITED STATES SENATE ONE HUNDRED THIRTEENTH CONGRESS FIRST SESSION JUNE 24, 2013 Available via the World Wide Web: http://www.fdsys.gov/ Printed for the use of the Committee on Homeland Security and Governmental Affairs ( U.S. GOVERNMENT PRINTING OFFICE 82–571 PDF WASHINGTON : 2014 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 COMMITTEE ON HOMELAND SECURITY AND GOVERNMENTAL AFFAIRS THOMAS R. CARPER, Delaware Chairman CARL LEVIN, Michigan TOM COBURN, Oklahoma MARK L. PRYOR, Arkansas JOHN MCCAIN, Arizona MARY L. LANDRIEU, Louisiana RON JOHNSON, Wisconsin CLAIRE MCCASKILL, Missouri ROB PORTMAN, Ohio JON TESTER, Montana RAND PAUL, Kentucky MARK BEGICH, Alaska MICHAEL B. ENZI, Wyoming TAMMY BALDWIN, Wisconsin KELLY AYOTTE, New Hampshire HEIDI HEITKAMP, North Dakota JEFF CHIESA, New Jersey RICHARD J. KESSLER, Staff Director JOHN P. KILVINGTON, Deputy Staff Director PETER P. TYLER, Senior Professional Staff Member WALTER S. OCHINKO, GAO Detailee KEITH B. ASHDOWN, Minority Staff Director CHRISTOPHER J. BARKLEY, Minority Deputy Staff Director JOSH TRENT, Health Policy Advisor, Office of Senator Coburn TRINA D. SHIFFMAN, Chief Clerk LAURA W. KILBRIDE, Hearing Clerk (II) C O N T E N T S Opening statements: Page Senator Carper ................................................................................................. 1 Senator Coburn ................................................................................................. 3 Senator Chisea .................................................................................................. 4 Prepared statements: Senator Carper ................................................................................................. 37 WITNESSES MONDAY, JUNE 24, 2013 Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice ...... 6 Jonathan Blum, Acting Principal Deputy Administrator and Director of the Center for Medicare, Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services ...................................................... 8 Gary Cantrell, Deputy Inspector General for Investigations, Office of Inspec- tor General, U.S. Department of Health and Human Services; and Stuart Wright, Deputy Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services ......... 10 Alanna M. Lavelle, Director, Special Investigations, WellPoint, Inc. ................. 12 ALPHABETICAL LIST OF WITNESSES Blum, Jonathan: Testimony .......................................................................................................... 8 Prepared statement .......................................................................................... 56 Cantrell, Gary: Testimony .......................................................................................................... 10 Prepared statement .......................................................................................... 72 Lavelle, Alanna M.: Testimony .......................................................................................................... 12 Prepared statement .......................................................................................... 82 Rannazzisi, Joseph T.: Testimony .......................................................................................................... 6 Prepared statement .......................................................................................... 43 Wright, Stuart: Testimony .......................................................................................................... 10 Prepared statement .......................................................................................... 72 APPENDIX List referenced by Senator Carper ......................................................................... 41 Statement of the National Community Pharmacists Association ....................... 97 Responses to post-hearing questions for the Record: Mr. Rannazzisi .................................................................................................. 100 Mr. Blum ........................................................................................................... 103 Mr. Cantrell and Mr. Wright ........................................................................... 117 Ms. Lavelle ........................................................................................................ 123 (III) CURBING PRESCRIPTION DRUG ABUSE IN MEDICARE MONDAY, JUNE 24, 2013 U.S. SENATE, COMMITTEE ON HOMELAND SECURITY AND GOVERNMENTAL AFFAIRS, Washington, DC. The Committee met, pursuant to notice, at 3:08 p.m., in room SD–342, Dirksen Senate Office Building, Hon. Thomas R. Carper, Chairman of the Committee, presiding. Present: Senators Carper, Coburn, and Chiesa. OPENING STATEMENT OF CHAIRMAN CARPER Chairman CARPER. Well, a room as quiet as this one probably does not need me to call everyone to order, but this hearing will come to order, and I want to welcome our witnesses. I apologize for running a few minutes late, but thank you for being here and for your preparation and attendance today for an important hearing. Our colleagues are coming in from across the country this after- noon, and we will be joined by a number of them as this hearing proceeds. Today we are going to hear from several witnesses about the Medicare Prescription Drug Program and its vulnerability to waste, to fraud, and to abuse. Medicare, as we all know, is a critical component of health care in our Nation, and the Prescription Drug Program, which we know as Part D, began about 7 years ago, in 2006. We are now in its sev- enth year. The overall reviews of the program have been generally positive, more than 31 million seniors participating. The lion’s share of them like the program. However, Congress must ensure that the $60 billion a year program works effectively and effi- ciently. Unfortunately, Medicare, including Part D, is not as effec- tive or efficient as it could or should be when it comes to pre- venting waste and fraud. Each year, the Federal Government lists the estimates of over- payments, underpayments, undocumented expenditures, and other kinds of mistakes made by each agency. The total for fiscal year (FY) 2012 was more than $100 billion. Medicare has the largest re- ported share of that total at $44.3 billion, and the amount wasted in Medicare’s Prescription Drug Program alone is approaching $1.6 billion. In addition, health care is too often the focus of criminals who wish to take advantage of the system. Whether the care is provided through government programs or the private sector, attempts to (1) 2 defraud the health care system are on the rise. There are estimates for Medicare fraud in the tens of billions of dollars. We cannot afford to tolerate these levels of waste and fraud in our health care programs. As everyone in this room knows, we have faced record budget deficits in recent years, and while they are coming down, they are still way too large. Given the debt and deficit problems that our country faces and the tough work ahead of us as we attempt to address those challenges, we need to focus like a laser on the avoidable, expensive, and, frankly, unacceptable issues we will be discussing here today. During a Subcommittee hearing that I chaired in the fall of 2011—and I might be mistaken, but I think Dr. Coburn was there as well. I am not positive. I think you were, because of your great interest. But the Government Accountability Office (GAO) that day testified that they identified about 170,000 beneficiaries who ac- quired the same class of frequently abused drugs, primarily hydrocodone and oxycodone, from five or more medical practi- tioners at a taxpayer cost of almost $150 million. In two egregious examples, individuals received prescriptions from 87 and 58 dif- ferent medical practitioners. This followed a similar study by the GAO in 2009 showing the same problem in Medicaid. This fraud technique, called ‘‘doctor shopping,’’ involves recipi- ents going to multiple doctors for the same type of drug. In these cases, beneficiaries are almost always either feeding an addiction or selling the drugs they do not use on the street. Drug dealers make the profits while the Federal Government foots the bill. But the problem of prescription drug fraud is about more than just a loss of taxpayer dollars. It is also about the toll that drug abuse takes on people. It is of great concern that one out of seven high school seniors in America has abused, or is abusing, prescrip- tion drugs. In fact, more Americans abuse prescription drugs than the number who abuse cocaine, heroin, hallucinogens, Ecstasy, and inhalants combined. The Department of—do we have a chart here anywhere? The Department of Health and Human Services (HHS), specifi- cally the Centers for Medicare & Medicaid Services (CMS), has es- tablished a set of oversight procedures to protect the Medicare Pre- scription Drug Program and its beneficiaries from fraud and waste. This is a team effort involving Medicare officials, law enforcement at the Federal, the State, and the local level, the Medicare pre- scription drug plans
Load more

Recommended publications
  • Pharmacy/Prescription Drug Fraud Tips for Protecting Yourself and Medicare
    Pharmacy/Prescription Drug Fraud Tips for Protecting Yourself and Medicare Pharmacy and prescription drug fraud is a consistent trend in Medicare. Due to the lucrative nature of prescription drug diversion and pharmacy scams, criminals continue to exploit Medicare Part D. What is Medicare Pharmacy/Prescription Drug Fraud? Although there are many types of prescription drug schemes, pharmacy fraud primarily occurs when Medicare is billed for a medication that was not received or a beneficiary is intentionally given a different prescription drug than prescribed. What are Examples of Pharmacy/Prescription Drug Fraud? • Billing Medicare for prescription drugs (including refills) that were never picked up, delivered, or even prescribed. • Billing Medicare for prescription drugs (occasionally controlled substances such as opioids) that were prescribed by a health care provider you have never seen. • Billing Medicare for medication amounts beyond the quantity you were prescribed. • Billing Medicare for a different prescription drug (often more expensive) than the one you were originally prescribed or issuing you a drug that is not approved by the U.S. Food and Drug Administration (FDA). • A pharmacy that intentionally provides less medication than prescribed. • A pharmacy that issues expired drugs. • A pharmacy that provides and bills for an expensive compounded medication, including topical pain creams, when a traditional or less expensive prescription was ordered by your provider. • A company offering you “free” or “discount” prescription drugs without a treating physician’s order and then billing Medicare. • A pharmacy offering gift cards or other compensation so you switch your prescriptions over to a specific pharmacy. • A pharmacy automatically refilling a prescription you no longer need.
    [Show full text]
  • Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2019
    The Department of Health and Human Services And The Department of Justice Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2019 June 2020 TABLE OF CONTENTS I. Executive Summary 1 II. Statutory Background 3 III. Program Results and Accomplishments 5 Monetary Results 5 Expenditures 7 Overall Recoveries 8 Health Care Fraud Prevention and Enforcement Action Team 8 Health Care Fraud Prevention Partnership 10 Strike Forces 10 Opioid Fraud and Abuse Detection Unit 13 Highlights of Successful Criminal and Civil Investigations 14 IV. Department of Health and Human Services 39 Office of Inspector General 39 Centers for Medicare & Medicaid Services 61 Administration on Community Living 85 Office of the General Counsel 88 Food and Drug Administration Pharmaceutical Fraud Program 91 V. Department of Justice 95 United States Attorneys 95 Civil Division 96 Criminal Division 102 Civil Rights Division 107 Department of Justice Office of Inspector General 110 VI. Appendix 112 Federal Bureau of Investigation 112 Return on Investment Calculation 116 Total HCFAC Resources 117 VII. Glossary of Terms 118 GENERAL NOTE All years are fiscal years unless otherwise stated in the text. EXECUTIVE SUMMARY The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established a national Health Care Fraud and Abuse Control Program (HCFAC or the Program) under the joint direction of the Attorney General and the Secretary of the Department of Health and Human Services (HHS),1 acting through the Inspector General, designed to coordinate federal, state and local law enforcement activities with respect to health care fraud and abuse. In its twenty-third year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries.
    [Show full text]
  • Mail Fraud: Opening Letters
    South Carolina Law Review Volume 43 Issue 2 Article 3 Winter 1992 Mail Fraud: Opening Letters Ellen S. Podgor Georgia State University College of Law Follow this and additional works at: https://scholarcommons.sc.edu/sclr Part of the Law Commons Recommended Citation Podgor, Ellen S. (1992) "Mail Fraud: Opening Letters," South Carolina Law Review: Vol. 43 : Iss. 2 , Article 3. Available at: https://scholarcommons.sc.edu/sclr/vol43/iss2/3 This Article is brought to you by the Law Reviews and Journals at Scholar Commons. It has been accepted for inclusion in South Carolina Law Review by an authorized editor of Scholar Commons. For more information, please contact [email protected]. Podgor: Mail Fraud: Opening Letters SOUTH CAROLINA LAW REVIEW VOLUME 43 WINTER 1992 NUMBER 2 MAIL FRAUD: OPENING LETTERS ELLEN S. PODGOR* I. INTRODUCTION ....................................... 224 II. ELEMENTS ........................................... 225 A. First Element-Scheme to Defraud ............... 226 B. Second Element-Mailing in Furtherance of Schem e ........................................ 229 C. Mail Fraud As It Relates to Wire Fraud and RICO 231 III. SCHEME TO DEFRAUD ................................. 232 A. Intangible Rights Doctrine ....................... 232 B. 1346 Ramifications .............................. 236 IV. IN FURTHERANCE ..................................... 239 A . Conduct ........................................ 240 B. Lim itations ..................................... 242 1. Conflicts with Scheme to Defraud............. 243 2. Imperative Duty Imposed by State ........... 245 3. Mailing Prior to Commencement of Scheme ... 247 * Associate Professor of Law, Georgia State University College of Law. B.S. 1973, Syracuse University; J.D. 1976, Indiana University School of Law at Indianapolis; M.B.A. 1987, University of Chicago; L.L.M. 1989, Temple University School of Law. The author wishes to thank Professors Alfredo Garcia, Eli Lederman, and Laura Webster for their helpful comments throughout the drafting of this article.
    [Show full text]
  • Prescription Drug Fraud and Misuse, 2Nd Edition
    Problem-Specific Guides Series Problem-Oriented Guides for Police No. 24 Prescription Drug Fraud and Misuse 2nd Edition Julie Wartell and Nancy G. La Vigne Problem-Oriented Guides for Police Series Problem-Specific Guide No. 24 Prescription Drug Fraud and Misuse 2nd Edition Julie Wartell Nancy G. La Vigne This project was supported by cooperative agreement #2010-CK-WX-K005 awarded by the Office of Community Oriented Policing Services, U.S. Department of Justice. The opinions contained herein are those of the author(s) and do not necessarily represent the official position or policies of the U.S. Department of Justice. References to specific agencies, companies, products, or services should not be considered an endorsement of the product by the author(s) or the U.S. Department of Justice. Rather, the references are illustrations to supplement discussion of the issues. The Internet references cited in this publication were valid as of the date of this publication. Given that URLs and websites are in constant flux, neither the author(s) nor the COPS Office can vouch for their current validity. © 2013 Center for Problem-Oriented Policing, Inc. The U.S. Department of Justice reserves a royalty-free, nonexclusive, and irrevocable license to reproduce, publish, or otherwise use, and authorize others to use, this publication for Federal Government purposes. This publication may be freely distributed and used for noncommercial and educational purposes. www.cops.usdoj.gov ISBN: 978-1-932582-37-6 April 2013 Originally published May 2004 Updated
    [Show full text]
  • January - December 1992
    January - December 1992 1869 Partnership A&J Cleaning Service A.M. Kirsch Construction Inc. New Business Names, BJ New Business Names, BJ New Business Names, BJ 7/27/92 p21 1/20/92 p21 10/12/92 p20 85 West Street Associates A&M Construction A.P.Z. Painting New Business Names, BJ New Business Names, BJ 6/8/92 New Business Names, BJ 11/23/92 p20 p25 3/30/92 p20 911. SEE EMERGENCY A&M Vending A.R.M.S. of Connecticut COMMUNICATION SYSTEMS New Business Names, BJ New Business Names, BJ 7SS Mailorder 8/17/92 p22 11/9/92 p20 New Business Names, BJ A&S Investment A.R.S. 9/21/92 p20 New Business Names, BJ New Business Names, BJ 313-18 Federal Road Corp. 10/5/92 p20 2/17/92 p33 Bankruptcies, BJ 10/5/92 p19 A&S Laundrette A.S. Construction Service 34 Wall Street Building Account New Business Names, BJ New Business Names, BJ New Business Names, BJ 6/22/92 p13 7/13/92 p20 2/17/92 p33 A&V Variety A.V.R. Electronics 3-Star Screen Printing & Athletic New Business Names, BJ New Business Names, BJ Accessories 2/10/92 p20 9/21/92 p20 New Business Names, BJ A-1 Auto Painting & Bodywork AA Malloy Insurance 4/13/92 p20 New Business Names, BJ New Business Names, BJ 3P Industries 11/9/92 p21 7/27/92 p21 New Business Names, BJ A-1 Medical & Executive AAA Services 4/13/92 p20 Answering Service New Business Names, BJ 20 Orchard Street Corp.
    [Show full text]
  • Office of Statewide Prosecution 2003 Annual Report
    OFFICE OF STATEWIDE PROSECUTION 2003 ANNUAL REPORT Submitted by Peter Williams, Statewide Prosecutor March 1, 2004 Charlie Crist Peter Williams Attorney General Statewide Prosecutor OFFICE OF STATEWIDE PROSECUTION 2003 ANNUAL REPORT This Annual Report for the Office of Statewide Prosecution is being filed pursuant to Section 16.56 (2), Florida Statutes, and contains a summary of the activities of the Office for 2003 as well as the goals and objectives for 2004. EXECUTIVE SUMMARY OF THE OFFICE’S ACTIVITIES In Fiscal Year 2002-2003, the Office of Statewide Prosecution handled a total volume of 1,000 complex criminal investigations and prosecutions, including 628 filed cases and worked in conjunction with 101 law enforcement agencies and numerous State and Federal Task Forces. This volume was achieved in spite of a ten percent budget cut for Fiscal Year 2003-2004, and represents a six percent increase in the number of filed cases over the prior fiscal year. The overall conviction rate was 91%. The financial benefit to the citizens of the State of Florida in the form of assessed fines, penalties, and ordered restitution amounted to over $27 million, which greatly exceeded the total operating budget of the Office of Statewide Prosecution. MISSION OF THE OFFICE The Office of Statewide Prosecution was created by constitutional amendment passed by Florida voters in 1986. Article IV, Section 4 of the Florida Constitution, together with Section 16.56, Florida Statutes, sets forth the jurisdiction and authority of the Office. The Office was created because organized criminal activity does not respect the geographic boundaries imposed by judicial circuit lines.
    [Show full text]
  • Page 1 of 4 Drug-Abuse Problems Evade Part D Anti-Fraud Efforts
    Drug-abuse problems evade Part D anti-fraud efforts | Modern Healthcare Page 1 of 4 ACA ACOs Finance Government Healthcare IT Payers Physicians Safety/Quality Supply Chain Log in | Free Newsletters | Subscribe | Get Password | Help Join, Follow & Connect News Topics Research Opinion Blog Recognition Videos & Webinars Events Marketplace Jobs Healthcare Business News This Week's Issue Painful side effects Outlook 2014: Drug-abuse problems evade paltry anti-fraud efforts in Medicare Part D Healthcare industry can expect promises, challenges and growth By Joe Carlson Posted: April 12, 2013 - 12:01 am ET Startup insurer Oscar Tags: Feature, Fraud, Legal, Medicare, Pharmaceuticals, Recovery Audit Inc. hopes high-tech, Contractor (RAC) service will trump incumbents Table of Contents The abuse of prescription painkillers causes more fatalities than heroin and Digital Edition Stanford team answers cocaine use combined—more than 40 deaths every day. Subscribe call to aid typhoon victims Yet programs that could stop the types of Medicare fraud that commonly lead to powerful drugs being diverted into the black market aren't working as well as they should. By the numbers: Uninsured young Such breakdowns are often framed largely in terms of financial losses, such as the widely touted statistic that prescription Americans by state drug fraud costs public and private insurers about $73 billion a year. But unlike other areas of Medicare fraud, prescription drug abuse levels a heavy human toll seen in the rising rates of deaths and addictions, the births of drug-addicted babies and destruction wrought on rural towns hard-hit by the painkiller epidemic. A report from the Government Accountability Office found in Advertisement | View Media Kit 2011 that 170,000 Medicare beneficiaries got prescription painkillers from five or more doctors, which is a warning sign Most Requested Articles for fraudulent “doctor-shopping” by drug-seeking individuals.
    [Show full text]
  • Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2015
    The Department of Health and Human Services And The Department of Justice Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2015 FEBRUARY 2016 TABLE OF CONTENTS I. Executive Summary 1 II. Statutory Background 3 III. Program Results and Accomplishments 5 Monetary Results 5 Expenditures 7 Overall Recoveries 8 Health Care Fraud Prevention and Enforcement Action Team 8 Health Care Fraud Prevention Partnership 9 Medicare Fraud Strike Force 10 Highlights of Successful Criminal and Civil Investigations 12 IV. Department of Health and Human Services 36 Office of Inspector General 36 Centers for Medicare & Medicaid Services 45 Administration on Community Living 56 Office of the General Counsel 58 Food and Drug Administration Pharmaceutical Fraud Program 62 V. Department of Justice 64 United States Attorneys 64 Civil Division 66 Criminal Division 69 Civil Rights Division 72 VI. Appendix 77 Federal Bureau of Investigation 77 Return on Investment Calculation 80 Total HCFAC Resources 81 VII. Glossary of Terms 82 GENERAL NOTE All years are fiscal years unless otherwise noted in the text. EXECUTIVE SUMMARY The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established a national Health Care Fraud and Abuse Control Program (HCFAC or the Program) under the joint direction of the Attorney General and the Secretary of the Department of Health and Human Services (HHS)1, acting through the Inspector General, designed to coordinate federal, state and local law enforcement activities with respect to health care fraud and abuse. In its nineteenth year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries.
    [Show full text]
  • Health Frauds and Quackery Hearings
    HEALTH FRAUDS AND QUACKERY HEARINGS BEFORE THE SUBCOMMITTEE ON FRAUDS AND MISREPRE- SENTATIONS AFFECTING THE ELDERLY OF THE SPECIAL COMMITTEE ON AGING UNITED STATES SENATE EIGHTY-EIGHTH CONGRESS SECOND SESSION Part 1.-San Francisco, Calif. JANUARY 13, 1964 Printed for the use of the Special Committee on Aging U.S. GOVERNMENT PRINTING OFFICE 31-135 WASHINGTON: 1964 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington., D.C. 20402 -Price 45 cents SPECIAL COMMITTEE ON AGING GEORGE A. SMATHERS, Florida, Chairman PAT McNAMARA, Michigan EVERETT McKINLEY DIRKSEN, Illinois CLAIR ENGLE, California BARRY GOLDWATER, Arizona HARRISON A. WILLIAMS, JR., New Jersey FRANK CARLSON, Kansas MAURINE B. NEUBERGER, Oregon WINSTON L. PROUTY, Vermont WAYNE MORSE, Oregon KENNETH B. KEATING, New York ALAN BIBLE, Nevada HIRAM L. FONG, Hawaii FRANK CHURCH, Idaho E. L. MECHEM, New Mexico JENNINGS RANDOLPH, West Virginia EDMUND S. MUSKIE, Maine EDWARD V. LONG, Missouri FRANK E. MOSS, Utah EDWARD M. KENNEDY, Massachusetts RALPH W. YARBOROUGH, Texas J. WiLmamaa NORMAN, Jr., Staff Director JoHIN Guy MILLER, Minority Staff Director SUBCOMMITTEE ON FRAUDS AND MISREPRESENTATIONS AFFECTING TEE ELDERLY HARRISON A. WILLIAMS, JR., New Jersey, Chairman MAURINE B. NEUBERGER, Oregon KENNETH B. KEATING, New York WAYNE MORSE, Oregon WINSTON L. PROUTY, Vermont FRANK CHURCH, Idaho HIRAM L. FONG, Hawaii EDMUND S. MUSKIE, Maine E. L. MECHEM, New Mexico EDWARD V. LONG, Missouri EDWARD M. KENNEDY, Massachusetts RALPH W. YARBOROUGH, Texas WILLIAM E. ORIOL, Professional Staff Member NOTE.-Four hearings on health frauds and quackery were held and they are identified as follows: Part 1-San Francisco, Calif., Jan.
    [Show full text]
  • Smp Foundations Training Manual
    SMP Foundations Training Manual SMP Resource Center Table of Contents Acknowledgements ................................................................... i About the SMP Resource Center .............................................. i Training Overview .................................................................... ii Updates Since August 2014 ....................................................iii Chapter 1: SMP Program Objectives ................................................................................. 3 The SMP Mission ...................................................................... 3 SMP is a National Program....................................................... 6 The Importance of Volunteers................................................... 9 How Does the Public Find Their SMP? ................................... 10 Chapter 2: Medicare Basics Objectives ............................................................................... 13 Medicare Overview ................................................................. 14 Original Medicare .................................................................... 17 Medicare Part C: Medicare Advantage ................................... 24 Medicare Part D: Prescription Drugs ...................................... 26 Medicare Enrollment Periods .................................................. 27 Medicare Statements and Claims Tracking ............................ 33 Assistance for People with Limited Income and Resources ... 49 Medicare Rights and Protections ...........................................
    [Show full text]
  • Health Care Fraud and Abuse Control Program, Annual Report for Fiscal
    The Department of Health and Human Services And The Department of Justice Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2016 January 2017 TABLE OF CONTENTS I. Executive Summary 1 II. Statutory Background 3 III. Program Results and Accomplishments 5 Monetary Results 5 Expenditures 7 Overall Recoveries 8 Health Care Fraud Prevention and Enforcement Action Team 8 Health Care Fraud Prevention Partnership 9 Medicare Fraud Strike Force 10 Highlights of Successful Criminal and Civil Investigations 12 IV. Department of Health and Human Services 34 Office of Inspector General 34 Centers for Medicare & Medicaid Services 43 Administration on Community Living 60 Office of the General Counsel 62 Food and Drug Administration Pharmaceutical Fraud Program 66 V. Department of Justice 69 United States Attorneys 69 Civil Division 70 Criminal Division 74 Civil Rights Division 77 VI. Appendix 82 Federal Bureau of Investigation 82 Return on Investment Calculation 85 Total HCFAC Resources 86 VII. Glossary of Terms 87 GENERAL NOTE All years are fiscal years unless otherwise stated in the text. EXECUTIVE SUMMARY The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established a national Health Care Fraud and Abuse Control Program (HCFAC or the Program) under the joint direction of the Attorney General and the Secretary of the Department of Health and Human Services (HHS)1, acting through the Inspector General, designed to coordinate federal, state and local law enforcement activities with respect to health care fraud and abuse. In its twentieth year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries.
    [Show full text]
  • Increasing Pressure on Pbms to Identify Fraudulent Providers How Pbms Can Use Data, Analytics and Advanced Technology to Reduce Their Risk
    Increasing pressure on PBMs to identify fraudulent providers How PBMs can use data, analytics and advanced technology to reduce their risk In July 2017, the Justice Department arrested more than 400 people across the U.S. in a crackdown on healthcare fraud. The accused individuals were charged with billing Medicaid and Medicare for drugs that were never purchased, distributing unnecessary opioid prescriptions for cash and billing for false treatments.1 “Some doctors wrote out more prescriptions for controlled substances in one month than entire hospitals were writing,” Andrew McCabe, acting FBI director said.1 The fraud scheme cost the federal government $1.3 billion in fake Medicare and Medicaid billings. In October 2017, two pharmacists were charged in healthcare fraud schemes, allegedly defrauding Medicare, Tricare and major insurers out of more than $10 million. They took part in a conspiracy that employed improper contracts, kickbacks, mislabeled drugs and prescription forgeries, ultimately bilking millions of dollars from the federal health insurance program meant for America’s military members and their families,” said Jay Town, U.S. Attorney for the North district of Alabama.2 Unfortunately, those recent cases are just a few of the many schemes contributing to the billions of dollars lost each year through Medicare and Medicaid fraud and improper payments to providers, including pharmacists. The burden of catching that fraud is largely falling to Pharmacy Benefit Managers (PBMs). A tempting target The amount of money at stake and the tremendous volume of transactions make healthcare a natural target. In 2013 Medicaid doled out $415 billion; Medicare, nearly $600 billion.3 No one knows for sure how much of that went to fraudulent claims, including prescription claims.
    [Show full text]